OLYMPIA: TearCare treatment improves dry eye signs, symptoms

Sight Sciences’ TearCare treatment improved signs and symptoms of dry eye disease statistically significantly and clinically meaningfully, according to a study.
The OLYMPIA study compared a single TearCare treatment to a single LipiFlow (Johnson & Johnson Vision) treatment in a randomized, multicenter, masked study of 235 adults. Seventy percent of participants were women.
Tear breakup time (TBUT) and meibomian gland secretion score were statistically significantly improved at follow-up time points of 2 weeks and 1 month in both groups (P < .0001), thus meeting the study’s

Full Story →